Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(100.0%)
1Total
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT03145974Completed

Prevalence and Outcome of Acute Hypoxemic Respiratory Failure

Role: collaborator

NCT03358043Completed

Prevalence and Outcome of Acute Hypoxemic Respiratory Failure in Wales

Role: collaborator

NCT01731795Phase 4Completed

Efficacy Study of Dexamethasone to Treat the Acute Respiratory Distress Syndrome

Role: collaborator

NCT02288949Completed

Stratification of the Acute Respiratory Distress Syndrome

Role: collaborator

NCT02836444Completed

Stratification of the Acute Respiratory Distress Syndrome - A Second Phase Study

Role: collaborator

NCT00435110Completed

Effects of PEEP and FIO2 in ALI and ARDS

Role: collaborator

NCT01142544Completed

Incidence of Acute Lung Injury in Children

Role: collaborator

All 7 trials loaded